Gene Silencing Using Multifunctionalized Gold Nanoparticles for Cancer Therapy

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Molecular Biology

Background:

• Cancer theranostics require integrated platforms for targeting, detection, and therapeutic intervention.
• Gold nanoparticles (AuNPs) offer versatile platforms for biomedical applications due to their unique optical and physical properties.

Purpose of the Study:

• To develop and characterize a nano-integrated platform using gold nanobeacons (Au-nanobeacons) for simultaneous gene detection and silencing in cancer cells.
• To evaluate the efficacy and specificity of Au-nanobeacons in inhibiting KRAS gene expression in colorectal carcinoma cell lines.

Main Methods:

• Functionalization of AuNPs with targeting peptides for enhanced tumor cell recognition and uptake.
• Incorporation of fluorescently labeled antisense DNA hairpin oligonucleotides for target recognition and signal generation.
• Monitoring of intracellular interactions and gene silencing through fluorescence emission upon oligonucleotide hybridization.

Main Results:

• Demonstrated successful targeting and uptake of Au-nanobeacons in cancer cells.
• Achieved specific inhibition of KRAS gene expression in colorectal carcinoma cell lines.
• Observed no significant toxicity in healthy fibroblasts, indicating high specificity.

Conclusions:

• The developed Au-nanobeacon platform effectively integrates targeting, detection, and gene silencing for cancer theranostics.
• This adaptable platform shows potential for broad application in cancer diagnosis and treatment by targeting various genes.
• Au-nanobeacons represent a promising tool for advancing personalized cancer therapy.